Alnylam Pharmaceuticals, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2017 | 99.7M |
| FY2018 | 101.2M |
| FY2019 | 109.3M |
| FY2020 | 115.0M |
| FY2021 | 118.5M |
| FY2022 | 121.7M |
| FY2023 | 124.9M |
| FY2024 | 127.7M |
| FY2025 | 134.7M |
| FY2026 | 132.6M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2017 | 99.7M |
| FY2018 | 101.2M |
| FY2019 | 109.3M |
| FY2020 | 115.0M |
| FY2021 | 118.5M |
| FY2022 | 121.7M |
| FY2023 | 124.9M |
| FY2024 | 127.7M |
| FY2025 | 134.7M |
| FY2026 | 132.6M |